GlobalData on MSN8h
EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a combination therapy consisting of ...
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth
Delcath Systems sees strong growth in Q3 earnings, driven by HEPZATO and CHEMOSAT sales. Read my DCTH Q3 earnings analysis.
Why Are Younger People Getting Cancer?
Cancer is on the rise in America - especially among younger adults. Learn about what lifestyle choices may help to avoid early-onset cancer.